Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:46 pm Purchase | 2023-12-31 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Fairmount Funds Management LLC | 2,883,221 8.100% | 740,169 (+34.54%) | Filing History |
| 2024-02-13 5:07 pm Sale | 2023-12-29 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | VANGUARD GROUP INC | 2,965,299 8.370% | -261,592 (-8.11%) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Rubric Capital Management LP | 2,907,501 8.210% | 2,907,501 (New Position) | Filing History |
| 2024-01-25 1:48 pm Sale | 2023-12-31 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | BlackRock Inc. BLK | 3,180,588 9.000% | -247,153 (-7.21%) | Filing |
| 2023-08-18 4:32 pm Purchase | 2022-12-31 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | HHLR ADVISORS LTD. | 3,541,301 9.900% | 917,377 (+34.96%) | Filing History |
| 2023-08-10 4:15 pm Purchase | 2023-08-02 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Fairmount Funds Management LLC | 2,143,052 6.100% | 2,143,052 (New Position) | Filing History |
| 2023-03-08 2:15 pm Sale | 2023-02-28 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | BlackRock Inc. BLK | 3,427,741 4.900% | -153,938 (-4.30%) | Filing |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | HHLR ADVISORS LTD. | 2,623,924 7.600% | -296,099 (-10.14%) | Filing History |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | VANGUARD GROUP INC | 3,226,891 9.340% | 336,183 (+11.63%) | Filing History |
| 2023-02-03 11:51 am Sale | 2022-12-31 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | PICTET ASSET MANAGEMENT SA | 1,234,193 3.570% | -2,314,456 (-65.22%) | Filing History |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | BlackRock Inc. BLK | 3,581,679 5.200% | 15,697 (+0.44%) | Filing |
| 2022-09-08 1:43 pm Purchase | 2022-08-31 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | BlackRock Inc. BLK | 3,565,982 5.100% | 82,130 (+2.36%) | Filing |
| 2022-02-14 10:56 am Sale | 2021-12-31 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | AMERIPRISE FINANCIAL INC AMP | 285 0.000% | -2,370,951 (-99.99%) | Filing History |
| 2022-02-10 11:07 am Purchase | 2021-12-31 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | PICTET ASSET MANAGEMENT SA | 3,548,649 5.150% | 3,548,649 (New Position) | Filing History |
| 2022-02-10 08:22 am Purchase | 2021-12-31 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | VANGUARD GROUP INC | 2,890,708 8.530% | 354,287 (+13.97%) | Filing History |
| 2022-01-27 5:13 pm Unchanged | 2021-12-31 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | BlackRock Inc. BLK | 3,483,852 10.300% | 0 (Unchanged) | Filing |
| 2022-01-26 09:16 am Sale | 2021-12-31 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | BlackRock Inc. BLK | 3,483,852 10.300% | -34,037 (-0.97%) | Filing |
| 2021-11-24 3:40 pm Unchanged | 2021-10-31 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | BlackRock Inc. BLK | 3,517,889 10.400% | 0 (Unchanged) | Filing |
| 2021-11-10 09:43 am Purchase | 2021-10-31 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | BlackRock Inc. BLK | 3,517,889 10.400% | 3,517,889 (New Position) | Filing |